By Rick Archer (September 13, 2021, 6:01 PM EDT) -- A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7. 1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture. At a hearing held virtually, U. S. Bankruptcy Judge Robert Drain approved the incentive program and allowed the company to start work on setting up the opioid claims trust in its Chapter 11 plan, overruling arguments that this could cut off pending appeals of his decision to approve the plan. Purdue entered bankruptcy in September 2019 after reaching a deal with 24 state. . .
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Read Full Story: https://www.law360.com/personal-injury-medical-malpractice/articles/1421059/purdue-pharma-gets-ok-for-7-1m-in-exec-incentives
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.